home > ict > winter 2020 > the difference a step makes
International Clinical Trials

The Difference a Step Makes

It’s a relatively calm and quiet Friday afternoon, until you hear it, the chime of a new email coming through your speakers. “Urgent: Class II recall of Molecule RFGH79245 – Lot XFD157899,” the subject line reads. Now, in just a moment’s time, what was once a quiet office environment has turned into a cacophony of conversations regarding vendor processes, systems, who has the latest Excel tracker, and more.

Regrettably, this is the scene of several pharmaceutical companies, moments after receiving a lot recall notice for a clinical trial. In fact, many organisations in trials lag behind their commercial counterparts in terms of trial supply sophistication and visibility. While manual systems and processes can work, they often present serious hurdles for those looking to accurately forecast, predict, and solve clinical trial supply issues. As the introduction illustrates, manual processes can quickly become an administrative nightmare any time there’s a serious bump in the road.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

About the author

The best technology succeeds in the background. Signant Health provides solutions that simplify every step of the patient journey to make it easier for people to participate in, and for sites and study teams to run, clinical trials. Signant unites eCOA, eConsent, patient engagement, interactive response technology, clinical supplies, and endpoint quality into the industry’s most comprehensive patient-centric suite – an evolution built on more than 20 years of proven clinical research technology. Our intense focus on the patient experience, deep therapeutic area expertise, and global operational scale enable hundreds of sponsors and CROs (including all top 20 pharma) to extend the reach of drug development, expand patient opportunities, and improve data quality – helping them bring lifechanging therapies to our families and communities around the world.
Print this page
Send to a friend
Privacy statement
News and Press Releases

WuXi STA Forms Strategic Partnership with Coherent Biopharma

Shanghai, 1st December 2021: WuXi STA – a subsidiary of WuXi AppTec – and Coherent Biopharma, announced the signing of a strategic partnership agreement.
More info >>

White Papers



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement